We first performed a Rh123 exclusion assay and CD34 + CD38− immunophenotyping in AML primary cells from nine patients (Table S1) to screen their ABCB1 activity and LSC compartment proportion. This evidence concerns the gene CD38 and acute myeloid leukemia.